Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 23;16(1):509.
doi: 10.1186/s12879-016-1847-x.

Development and validation of a novel single nucleotide polymorphism (SNP) panel for genetic analysis of Blastomyces spp. and association analysis

Affiliations

Development and validation of a novel single nucleotide polymorphism (SNP) panel for genetic analysis of Blastomyces spp. and association analysis

Holly M Frost et al. BMC Infect Dis. .

Abstract

Background: Single nucleotide polymorphism (SNP) genotyping is increasingly being utilized for molecular typing of pathogens and is cost-effective, especially for large numbers of isolates. The goals of this study were 1) to develop and validate a SNP assay panel for genetic analysis of Blastomyces spp., 2) ascertain whether microsatellite genotyping and the SNP genotyping with the developed panel resolve identical genetic groups, and 3) explore the utility of SNPs for examining phylogenetic and virulence questions in humans.

Methods: Three hundred sixty unique Blastomyces spp. isolates previously genotyped with microsatellite markers were genotyped with the MassARRAY® SNP genotyping system (Agena Bioscience™, San Diego, CA), for a custom panel of 28 SNPs. Clinical presentation data was analyzed for association with SNP variants.

Results: Three hundred twenty-three Blastomyces spp. isolates (90 %) were successfully genotyped by SNP analysis, with results obtained for at least 27 of 28 assays. For 99.7 % of isolates tested by both genotyping methods, microsatellite genetic group assignment correlated with species assignment based on internal transcribed spacer 2 (ITS2) genotyping, with Group 1 (Gr 1) being equivalent to B. gilchristii and Group 2 (Gr 2) being equivalent to B. dermatitidis. Thirteen isolates were genetic hybrids by one or both methods of genotyping and were difficult to assign to a particular genetic group or species. Fifteen SNP loci showed significantly different alleles in cases of pulmonary vs disseminated disease, at a p-value of <0.01 or less.

Conclusions: This study is the largest genotyping study of Blastomyces spp. isolates and presents a new method for genetic analysis with which to further explore the relationship between the genetic diversity in Blastomyces spp. and clinical disease presentation. We demonstrated that microsatellite Gr 1 is equivalent to B. gilchristii and Gr 2 is equivalent to B. dermatitidis. We also discovered potential evidence of infrequent recombination between the two Blastomyces spp. Several Blastomyces spp. SNPs were identified as associated with dissemination or pulmonary disease presentation, but additional work is needed to examine virulence SNPs separately within B. dermatitidis and B. gilchristii.

Keywords: B. dermatitidis; B. gilchristii; Blastomyces; Blastomycosis; Genotype; Microsatellite; SNP.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Principle coordinate analysis of the haplotypic pairwise covariance distance matrix. a Analysis of SNP data on 323 Blastomyces spp. isolates subsumed to 73 unique haplotypes. The first primary axis (Coordinate 1) explained 69 % of the variance between B. dermatitidis and B. gilchristii. b Analysis of microsatellite date on 360 isolates subsumed to 224 unique haplotypes. The first primary axis (Coordinate 1) explained 25 % of the variance between the genetic groups. The 3 isolates identified in the figure were genetic intermediates by 1 or both genotyping methods
Fig. 2
Fig. 2
Mean q-values (genetic membership threshold) from microsatellite STRUCTURE analysis for 13 “hybrid” haplotypes with K = 2

References

    1. Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am. 2003;17:21–40. doi: 10.1016/S0891-5520(02)00038-7. - DOI - PubMed
    1. Kwon-Chung K, Bennett J. Medical mycology. 2. Philadelphia: Lea & Febiger; 1992. pp. 248–279.
    1. Mandell G, Bennett J, Dolin R. Principles and practice of infectious diseases. 6. New York: Churchill Livingston; 2000. pp. 2733–2746.
    1. Carman WF, Frean JA, Crewe-Brown HH, Culligan GA, Young CN. Blastomycosis in Africa. A review of known cases diagnosed between 1951 and 1987. Mycopathologia. 1989;107:25–32. doi: 10.1007/BF00437587. - DOI - PubMed
    1. Meece JK, Anderson JL, Fisher MC, Henk DA, Sloss BL, et al. Population genetic structure of clinical and environmental isolates of Blastomyces dermatitidis based on 27 polymorphic microsatellite markers. Appl Environ Microbiol. 2011;17:5123–5131. doi: 10.1128/AEM.00258-11. - DOI - PMC - PubMed

LinkOut - more resources